Early Access — free while we kick the tires
EdgarHawk

BOLD Boundless Bio, Inc. Insider Trading

Latest: Insider Bought $715K of Shares · Jun 2026
1 filing analyzed · Latest 2026-06-29
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying

Historically, medium-priority insider buys have outperformed the S&P 500 by a median ~1% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 7,520, 2022-2026). Past results don't predict the future. How we measure this ↗

June 2026
2026-06-29
medium
286,333 shares
$714,768
@ $2.50
Significance 6/10

Kevin Tang (10% Owner) bought 286,333 shares at BOLD for $714,768.12 across 6 transactions; holdings rise to 2,533,845 shares (+12.7%).

Kevin Tang, a 10% owner, executed 6 separate purchases totaling 286,333 shares for $714,768.12 over four trading days (June 25–29, 2026) at prices ranging from $2.47 to $2.56, with a blended average of $2.50. The transaction increased his stake by 12.7% to 2,533,845 shares. The purchases occurred while the stock was trading at $2.45 (current price), down 12.2% from its 52-week high of $2.79 but up 69.0% over the prior 30 days and up 122.7% over the prior 90 days. Boundless Bio is unprofitable, with net income of $-13,555,000.00 and a market cap of $55,037,071.95. Across all prior open-market trades, Tang's cross-ticker track record shows 20 buys with average 90-day returns of +3.1%, though his win rate stands at 50.00%.

Insiders here also file at

Get alerts for BOLD

Add BOLD to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access